Relation between stage of endogenous fungal endophthalmitis and prognosis

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 244, Issue 7, 2006, Pages 816-820

  Takebayashi, Hiroshi ^a   Mizota, Atsushi ^a   Tanaka, Minoru ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

D glucan; Endogenous fungal endophthalmitis; Predisposing factors; Prognosis

Indexed keywords

ANTIFUNGAL AGENT; GLUCAN;

ADULT; AGED; ANAMNESIS; ANTERIOR EYE SEGMENT; ARTICLE; BLOOD ANALYSIS; CANDIDA ALBICANS; CLINICAL EXAMINATION; CONSULTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENDOPHTHALMITIS; FEMALE; HEALTH STATUS; HUMAN; HYPERALIMENTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MYCOSIS; OPHTHALMOLOGY; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE; SYMPTOMATOLOGY; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; COMBINED MODALITY THERAPY; ENDOPHTHALMITIS; EYE INFECTIONS, FUNGAL; FEMALE; FUNGEMIA; HUMANS; MALE; MICONAZOLE; MIDDLE AGED; PROGNOSIS; VISUAL ACUITY; VITRECTOMY;

EID: 33746316876     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-005-0182-5     Document Type: Article

References (20)

1. Barrie T (1987) The place of elective vitrectomy in the management of patients with Candida endophthalmitis. Graefes Arch Clin Exp Ophthalmol 225:107-113
2. Brod RD, Flynn HW Jr, Clarkson JG, Pflugfelder SC, Cullbertson WW, Miller D (1990) Endogenous Candida endophthalmitis: Management without intravenous amphotericin B. Ophthalmology 97:666-672
3. Brooks RG (1989) Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch Intern Med 149:2226-2228
4. Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE Jr, Wagener MW, Yu VL (1994) Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology 101:1302-1309
5. Edwards JE Jr, Bodey GP, Bowden RA, Buchner T, de Pauw BE, Filler SG, Ghannoum MA, Glauser M, Herbrecht R, Kauffman CA, Kohno S, Martino P, Mori T, Pfaller MA, Rex JH, Rogers TR, Rubin RH, Solomkin J, Viscoli C, Walsh TJ, White M (1997) International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 25:43-59
6. Essman TF, Flynn JW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE (1997) Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 28:185-194
7. Fung JC, Donta ST, Tilton RC (1986) Candida detection system (CAND-TEC) to differentiate between Candida albicans colonization and disease. J Clin Microbiol 24:542-547
8. Hidaka A, Ninomiya H, Kobayashi Y, Tanaka M (1994) The studies on routine ophthalmological check up in a patient receiving intravenous hyperalimentation (IVH). Jpn J Clin Ophthalmol 48:950-951
9. Laatikainen L, Tuominen M, Von Dickhoff T (1992) Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy. Am J Ophthalmol 113:205-207
10. Obayashi T, Obayashi T, Yoshida M, Mori T, Goto H, Yasuda A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A (1995) Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345:17-21
11. Parke DW II, Jpnes DB, Gentry LO (1982) Endogenous endophthalmitis among patients with candidemia. Ophthalmology 89:789-796
12. Pfaller MA, Houston A, Coffmann S (1996) Application of CHROMagar candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (torulopsis) glabrata. J Clin Microbiol 34:58-61
13. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751-758
14. Pittet D, Anaissie E, Solomkin JS (1996) When to start antifungal therapy in the non-neutropenic critically ill? In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 567-577
15. Price MF, Gentry LO (1986) Incidence and significance of candida antigen in low-risk and high-risk patient populations. Eur J Clin Microbiol 5:416-419
16. Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D (2004) Culture-proven endophthalmitis: Clinical features and visual acuity outcomes. Am J Ophthalmol 137:725-731
17. Schulman JA, Peyman GA (1992) Intravenous corticosteroids as an adjunct in the treatment of bacterial and fungal endophthalmitis. Retina 12:336-340
18. Tanaka M, Kobayashi Y, Takebayashi H, Kiyokawa M, Qui H (2001) Analysis of predisposing clinical and laboratory findings for the development of endogenous fungal endophthalmitis. A retrospective 12-year study of 79 eyes of 46 patients. Retina 21:203-209
19. Urbak SF, Degn T (1992) Fluconazole in the treatment of Candida albicans endophthalmitis. Acta Ophthalmol 70:528-529
20. Voss A, le Noble JL, Verduyn Lunel FM, Foundrain NA, Meis JF (1997) Candidemia in intensive care unit patients: Risk factors for mortality. Infection 25:8-11